NYSE:PBH Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis $48.02 +0.02 (+0.04%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$47.95 -0.07 (-0.14%) As of 05/22/2026 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Prestige Consumer Healthcare Stock (NYSE:PBH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PBH alerts:Sign Up Key Stats Today's Range$47.18▼$48.4250-Day Range$45.95▼$62.7752-Week Range$42.62▼$87.12Volume947,407 shsAverage Volume803,825 shsMarket Capitalization$2.27 billionP/E Ratio12.28Dividend YieldN/APrice Target$70.75Consensus RatingHold Company Overview Prestige Consumer Healthcare, Inc. is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health. Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy). Prestige distributes its products primarily in the United States and Canada through supermarket, drug store, mass merchandise, dollar, club and e-commerce channels, and selectively in other markets through export partnerships. Formed through a series of strategic acquisitions of established consumer healthcare names, Prestige Consumer Healthcare has grown by integrating well-known OTC brands under a centralized commercial and operational platform. The company is headquartered in Tarrytown, New York, and leverages a focused R&D and regulatory support team to drive incremental innovation across its brand portfolio. Tony Long has served as President and Chief Executive Officer since December 2019, leading initiatives to expand Prestige’s market presence and enhance its category leadership.AI Generated. May Contain Errors. Read More Prestige Consumer Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScorePBH MarketRank™: Prestige Consumer Healthcare scored higher than 73% of companies evaluated by MarketBeat, and ranked 183rd out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingHold Consensus RatingPrestige Consumer Healthcare has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and 1 sell rating.Upside PotentialPrestige Consumer Healthcare has a consensus price target of $70.75, representing about 47.3% upside from its current price of $48.02.Amount of Analyst CoveragePrestige Consumer Healthcare has only been the subject of 4 research reports in the past 90 days.Read more about Prestige Consumer Healthcare's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.54% Earnings GrowthEarnings for Prestige Consumer Healthcare are expected to grow by 8.54% in the coming year, from $4.45 to $4.83 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Prestige Consumer Healthcare is 12.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Prestige Consumer Healthcare is 12.28, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.22.Price to Earnings Growth RatioPrestige Consumer Healthcare has a PEG Ratio of 1.54. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrestige Consumer Healthcare has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Prestige Consumer Healthcare's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.26% of the float of Prestige Consumer Healthcare has been sold short.Short Interest Ratio / Days to CoverPrestige Consumer Healthcare has a short interest ratio ("days to cover") of 6.68.Change versus previous monthShort interest in Prestige Consumer Healthcare has recently increased by 26.98%, indicating that investor sentiment is decreasing significantly. Dividend0.8 / 5Dividend StrengthN/A Dividend YieldPrestige Consumer Healthcare does not currently pay a dividend.Dividend GrowthPrestige Consumer Healthcare does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Prestige Consumer Healthcare will have a dividend payout ratio of 39.34% next year. This indicates that Prestige Consumer Healthcare will be able to sustain or increase its dividend. News and Social Media1.6 / 5News Sentiment-0.39 News SentimentPrestige Consumer Healthcare has a news sentiment score of -0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Prestige Consumer Healthcare this week, compared to 3 articles on an average week.Search Interest5 people have searched for PBH on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Prestige Consumer Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $85,514.00 in company stock.Percentage Held by Insiders1.40% of the stock of Prestige Consumer Healthcare is held by insiders.Percentage Held by Institutions99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Prestige Consumer Healthcare's insider trading history. Receive PBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PBH Stock News HeadlinesPBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law FirmMay 24 at 3:00 PM | globenewswire.comSecurities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading ...May 22 at 6:45 PM | tmcnet.comSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.May 25 at 1:00 AM | Brownstone Research (Ad)Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMay 22 at 6:45 PM | tmcnet.comSecurities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmMay 22 at 6:01 PM | businesswire.comPrestige Consumer Healthcare (PBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 22 at 3:00 PM | businesswire.comSecurities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMay 22 at 12:55 PM | businesswire.comInsider Selling: Prestige Consumer Healthcare (NYSE:PBH) VP Sells 346 Shares of StockMay 7, 2026 | insidertrades.comSee More Headlines PBH Stock Analysis - Frequently Asked Questions How have PBH shares performed this year? Prestige Consumer Healthcare's stock was trading at $61.69 at the beginning of 2026. Since then, PBH shares have decreased by 22.2% and is now trading at $48.02. How were Prestige Consumer Healthcare's earnings last quarter? Prestige Consumer Healthcare Inc. (NYSE:PBH) announced its quarterly earnings results on Wednesday, May, 13th. The company reported $1.23 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.39 by $0.16. The business's revenue was down 5.0% compared to the same quarter last year. Read the conference call transcript. Who are Prestige Consumer Healthcare's major shareholders? Top institutional shareholders of Prestige Consumer Healthcare include Dimensional Fund Advisors LP (5.65%), Allspring Global Investments Holdings LLC (3.29%), Boston Trust Walden Corp (1.36%) and Bank of America Corp DE (1.16%). Insiders that own company stock include Ronald M Lombardi, Jeffrey Zerillo, William P'pool, Adel Mekhail and Mary Beth Fritz. View institutional ownership trends. How do I buy shares of Prestige Consumer Healthcare? Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Prestige Consumer Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY). Company Calendar Last Earnings5/13/2026Today5/25/2026Next Earnings (Estimated)8/06/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 PBH's financial health is in the Red zone, according to TradeSmith. PBH has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED PRODUCTS Sub-IndustryPersonal Products Current SymbolNYSE:PBH CIK1295947 Webwww.prestigebrands.com Phone(914) 524-6800Fax302-674-5266Employees540Year Founded1996Price Target and Rating Average Price Target for Prestige Consumer Healthcare$70.75 High Price Target$80.00 Low Price Target$65.00 Potential Upside/Downside+47.3%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)$3.91 Trailing P/E Ratio12.28 Forward P/E Ratio10.79 P/E Growth1.54Net Income$190.30 million Net Margins17.48% Pretax Margin23.65% Return on Equity11.54% Return on Assets6.16% Debt Debt-to-Equity Ratio0.54 Current Ratio3.57 Quick Ratio2.25 Sales & Book Value Annual Sales$1.09 billion Price / Sales2.09 Cash Flow$5.21 per share Price / Cash Flow9.22 Book Value$39.84 per share Price / Book1.21Miscellaneous Outstanding Shares47,370,000Free Float46,709,000Market Cap$2.27 billion OptionableOptionable Beta0.40 Social Links 7 Stocks to Ride The A.I. MegaboomWe are about to experience the greatest A.I. boom in stock market history... Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s. That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom. Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day. And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly... Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy. Get This Free Report This page (NYSE:PBH) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
